Results 1 to 10 of about 4,909 (178)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review [PDF]

Pleura and Peritoneum, 2022
Small bowel adenocarcinoma (SBA) with peritoneal metastasis (PM) is rare and despite treatment with systemic chemotherapy, the prognosis is poor. However, there is emerging evidence that cytoreductive surgery (CRS) with hyperthermic intraperitoneal ...
Chen Vicky, Jones Morgan, Cohen Lauren, Yang Wilson, Bedi Jasman, Mohan Helen M., Apte Sameer S., Larach José Tomas, Flood Michael, Heriot Alexander, Kong Joseph, Warrier Satish   +11 more
doaj   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers [PDF]

International Journal of Molecular Sciences, 2022
Kuo-Hu Chen, I Hung Han
exaly   +2 more sources

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review [PDF]

Current Oncology, 2023
Winan van Houdt, Sophie Reijers, Van Houdt Winan J   +2 more
exaly   +2 more sources

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report

Saudi Journal of Anaesthesia, 2023
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs).
Nilanjana Howbora, Swaraj J Sonowal, Tridip J Borah, Sonai D Kakati, Anupam Das, Marie Ninu, Dokne Chintey   +6 more
doaj   +1 more source

Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre

Pleura and Peritoneum, 2022
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed the perioperative anesthetic management in patients undergoing HIPEC surgery.
Gupta Raghav, Gupta Nishkarsh, Sirohiya Prashant, Pandit Anuja, Ratre Brajesh Kumar, Vig Saurabh, Bhan Swati, Singh Ram, Kumar Balbir, Bhopale Shweta, Mishra Seema, Garg Rakesh, Bharati Sachidanand Jee, Kumar Vinod, Deo Suryanarayana, Bhatnagar Sushma   +15 more
doaj   +1 more source

Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae

Pleura and Peritoneum, 2022
Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais, Liauw Winston, Kennedy Helen, Alzahrani Nayef A., Morris David L.   +4 more
doaj   +1 more source

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey

Pleura and Peritoneum, 2021
Enhanced recovery after surgery (ERAS) protocols have been questioned in patients undergoing cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies.
Bhandoria Geetu, Solanki Sohan Lal, Bhavsar Mrugank, Balakrishnan Kalpana, Bapuji Cherukuri, Bhorkar Nitin, Bhandarkar Prashant, Bhosale Sameer, Divatia Jigeeshu V., Ghosh Anik, Mahajan Vikas, Peedicayil Abraham, Nath Praveen, Sinukumar Snita, Thambudorai Robin, Seshadri Ramakrishnan Ayloor, Bhatt Aditi   +16 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

International Journal of Hyperthermia, 2021
Purpose We aimed to determine the effects and possible mechanisms of hyperthermic intraperitoneal chemotherapy (HIPEC) in targeting ovarian cancer stem-like cells (CSCs).
Chao-Chih Wu, Yun-Ting Hsu, Chih-Long Chang   +2 more
doaj   +1 more source

Update of randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review

Pleura and Peritoneum, 2022
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with favorable short- and long-term oncological outcomes in highly selected patients with peritoneal metastasis (PM).
Noiret Barbara, Piessen Guillaume, Eveno Clarisse   +2 more
doaj   +1 more source

Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study

Pleura and Peritoneum, 2023
Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of
Charleux-Muller Diane, Fabacher Thibaut, Romain Benoit, Meyer Nicolas, Brigand Cécile, Delhorme Jean-Baptiste   +5 more
doaj   +1 more source